Association of sarcopenia with prognosis after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis
10.3969/j.issn.1001-5256.2021.12.041
- VernacularTitle:肝硬化肌少症与经颈静脉肝内门体分流术预后的关系
- Author:
Bangting ZHANG
1
;
Ying XU
1
;
Xuefang YANG
1
;
Xue ZHANG
1
Author Information
1. Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China
- Publication Type:Reviews
- Keywords:
Liver Cirrhosis;
Sarcopenia;
Portasystemic Shunt, Transjugular Intrahepatic;
Prognosis
- From:
Journal of Clinical Hepatology
2021;37(12):2932-2934
- CountryChina
- Language:Chinese
-
Abstract:
Sarcopenia is a common and insidious complication in patients with liver cirrhosis and is closely associated with the prognosis of patients with liver cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) is an important method for the treatment of portal hypertension-related complications. More and more studies have shown that sarcopenia is associated with the prognosis of cirrhotic portal hypertension after TIPS. This article reviews the research on sarcopenia and its association with TIPS in China and globally, in order to explore the association between them and guide clinical treatment.
